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Tubers of Corydalis cava were selected on the basis of bio-guided spectrophotometric 
Ellman´s method as a source of isoquinoline alkaloids for study of their selected biological 
activities. The tubers of Corydalis cava were extracted with ethanol and the mixture of 
summary tertiary alkaloids (fraction A) was fractionated in silica gel chromatography column 
using step gradient elution with hexane, chloroform and ethanol. Repeated column 
chromatography, preparative TLC and crystallization led to the isolation of fifteen 
isoquinoline alkaloids. The chemical structures of isolated compounds were determined on 
the basis of spectroscopic techniques and by comparison with literature data. Isolated 
alkaloids were tested on ability to inhibit AChE, serum BuChE (IC50), BACE1 and for its 
free-radical scavenging activity (EC50). 
The cholinesterase inhibitory activity was determined in vitro by modified 
spectrophotometric Ellman’s method. (+)-Canadaline inhibited AChE as well as BuChE in a 
dose-dependent manner with IC50 values 20.1 ± 1.1 μM and 85.2 ± 3.2 μM, respectively. (+)-
Canadine with an IC50 value 12.4 ± 0.9 μM was the most potent inhibitor of 
acetylcholinesterase, whilst (±)-corycavidine and (+)-bulbocapnine were effective inhibitors 
of butyrylcholinesterase with IC50 values 46.2 ± 2.4 μM and 67.0 ± 2.1 μM, respectively. 
Other isolated alkaloids were considered inactive (IC50 > 100 μM). 
The free-radical scavenging activity of isolated alkaloids was tested in vitro by means of 
the DPPH test. The highest activity was exhibited by (–)-scoulerine, (–)-sinoacutine and (+)-
bulbocapnine with EC50 values 102 ± 6.2 µM, 209 ± 8.1 µM and 279 ± 16.7 µM, respectively. 
Other isolated alkaloids were considered inactive (EC50 >1000 μM). 
BACE1 inhibitory activity of isolated alkaloids was measured by two different assays: 
multi-well plate format (FRET assay) and hrBACE1-IMER assay. FRET assay in solution 
studies was carried out on a multi-well spectrofluorimeter using M-2420 and Panvera 
substrates. The assay was performed by reading the fluorescence signal at λex/λem = 320/405 
nm and 544/590 nm, respectively. Panvera substrate was used for four compounds which 
were found to interfere with substrate M-2420 at λ = 405 nm. The hrBACE-IMER was 
inserted into a HPLC system and chromatographic analyses were performed using substrate 
M-2420. Fluorescence detector was set at 320 and 405 nm for excitation and emission 
wavelengths, respectively. (–)-Corycavamine and (+)-corynoline established their BACE1 
inhibitory activity in both FRET assay (IC50 = 41,16 µM and IC50 = 33,59 µM, respectively) 
and in the hrBACE-IMER assay (IC50 = 1690 µM and IC50 = 59,07 µM, respectively), other 
compounds were inactive or did not show a correlation between inhibitor concentration and 
enzyme inhibition. None of tested compounds can be considered as a good lead compound for 
BACE1 inhibition in comparison with BACE1 standard inhibitor IV (IC50 = 0.02 µM). Use of 
the above mentioned methods represents a suitable approach for the screening and 
determination of BACE1 inhibitory activity of tested compounds. 
 
